文献速递物质与行为成瘾焦虑、强迫与应激相关障碍精神分裂症与精神病性障碍

高 potency 大麻使用与青少年心理健康及物质使用的关联

Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence.
PubMed 文献 · JAMA Psychiatry · 2020-01-01

该队列研究基于英国 Avon 亲子纵向研究 1087 名 24 岁近期使用大麻的参与者,发现 13.0% 报告使用高 potency 大麻。高 potency 大麻使用与更频繁的大麻使用、大麻问题及焦虑障碍风险增加相关,调整使用频率后与精神病性体验、烟草依赖和其他非法药物使用的关联减弱。

要点

  • 高 potency 大麻使用与焦虑障碍风险增加相关(AOR 1.92)。
  • 高 potency 大麻使用与大麻使用频率及大麻问题增加相关。
  • 调整使用频率后,与精神病性体验等关联无统计学意义。

核心结论

  • 高 potency 大麻使用与心理健康及成瘾问题相关,限制其可获得性可能减少相关障碍。

研究设计与样本

  • 英国出生队列研究,纳入 1087 名 24 岁报告近期使用大麻的参与者,数据收集于 2015 年 6 月至 2017 年 10 月。

主要发现

  • 141 名参与者(13.0%)报告使用高 potency 大麻。
  • 高 potency 大麻使用与更频繁的大麻使用(AOR 4.38;95% CI 2.89-6.63)和大麻问题(AOR 4.08;95% CI 1.41-11.81)相关。
  • 高 potency 大麻使用与焦虑障碍风险增加相关(AOR 1.92;95% CI 1.11-3.32)。
  • 调整大麻使用频率后,与精神病性体验(AOR 1.29;95% CI 0.67-2.50)、烟草依赖(AOR 1.42;95% CI 0.89-2.27)和其他非法药物使用(AOR 1.29;95% CI 0.77-2.17)的关联减弱。
  • 未发现高 potency 大麻使用与酒精使用障碍或抑郁的关联证据。

临床怎么用

  • 临床评估大麻使用时,应询问大麻 potency 类型,高 potency 使用提示更高的大麻使用问题及焦虑风险。

局限性

  • 研究使用二手数据,假设在数据收集后形成;自我报告大麻类型可能存在错分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cannabis use is consistently linked to poorer mental health outcomes, and there is evidence that use of higher-potency cannabis increases these risks. To date, no studies have described the association between cannabis potency and concurrent mental health in a general population sample or addressed confounding using longitudinal data. OBJECTIVE: To explore the association between cannabis potency and substance use and mental health outcomes, accounting for preceding mental health and frequency of cannabis use. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from the Avon Longitudinal Study of Parents and Children, a UK birth cohort of participants born between April 1, 1991, and December 31, 1992. Present data on outcomes and exposures were collected between June 2015 and October 2017 from 1087 participants at 24 years of age who reported recent cannabis use. EXPOSURES: Self-reported type of cannabis most commonly used in the past year, coded to a binary exposure of use of high-potency cannabis or lower-potency cannabis. MAIN OUTCOMES AND MEASURES: Outcomes were reported frequency of cannabis use, reported cannabis use problems, recent use of other illicit drugs, tobacco dependence, alcohol use disorder, depression, generalized anxiety disorder, and psychotic-like experiences. The study used secondary data; consequently, the hypotheses were formulated after data collection. RESULTS: Past-year cannabis use was reported by 1087 participants (580 women; mean [SD] age at onset of cannabis use, 16.7 [3.0] years). Of these, 141 participants (13.0%) reported the use of high-potency cannabis. Use of high-potency cannabis was associated with increased frequency of cannabis use (adjusted odds ratio [AOR], 4.38; 95% CI, 2.89-6.63), cannabis problems (AOR, 4.08; 95% CI, 1.41-11.81), and increased likelihood of anxiety disorder (AOR, 1.92; 95% CI, 1.11-3.32). Adjustment for frequency of cannabis use attenuated the association with psychotic experiences (AOR 1.29; 95% CI, 0.67-2.50), tobacco dependence (AOR, 1.42; 95% CI, 0.89-2.27), and other illicit drug use (AOR, 1.29; 95% CI, 0.77-2.17). There was no evidence of association between the use of high-potency cannabis and alcohol use disorder or depression. CONCLUSIONS AND RELEVANCE: To our knowledge, this study provides the first general population evidence suggesting that the use of high-potency cannabis is associated with mental health and addiction. Limiting the availability of high-potency cannabis may be associated with a reduction in the number of individuals who develop cannabis use disorders, the prevention of cannabis use from escalating to a regular behavior, and a reduction in the risk of mental health disorders.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hines LA, Freeman TP, Gage SH, et al. Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence. JAMA Psychiatry. 2020. PMID: 32459328. doi:10.1001/jamapsychiatry.2020.1035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。